Skip to main content

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

MENLO PARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on August 2, 2023. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Conference Call Information

Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number, and a unique access PIN. Each access PIN will accommodate one caller.

Additionally, a listen-only webcast will be available by clicking here.

A replay of the call will be available on the Investors / Events tab of www.corcept.com.

About Corcept Therapeutics

Corcept has discovered a large portfolio of proprietary compounds that selectively modulate the effects of cortisol and owns extensive United States and foreign intellectual property covering both their composition and their use to treat a variety of serious disorders. Clinical trials are being conducted with the company’s leading selective cortisol modulators as potential treatments for patients with serious disorders – Cushing’s syndrome, ovarian, prostate and adrenal cancer, ALS, post-traumatic stress disorder and liver disease. Corcept’s drug Korlym® was the first medication approved by the U.S. Food and Drug Administration for the treatment of patients with Cushing’s syndrome.

CONTACT:
Corcept Therapeutics
For Investor inquiries:
ir@corcept.com
For Media inquiries:
CorceptCommunications@corcept.com
www.corcept.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.55
-4.48 (-2.02%)
AAPL  259.94
-2.83 (-1.08%)
AMD  232.06
-5.97 (-2.51%)
BAC  50.90
-0.62 (-1.21%)
GOOG  253.95
+2.61 (1.04%)
META  732.34
-0.93 (-0.13%)
MSFT  522.61
+4.95 (0.96%)
NVDA  180.82
-0.34 (-0.19%)
ORCL  272.23
-2.92 (-1.06%)
TSLA  434.49
-8.11 (-1.83%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.